Maxidex (Dexamethasone)

Maxidex is a glucocorticoid eye drop that targets ocular inflammatory pathways. It is indicated for several recognized eye conditions:

• Post‑operative ocular inflammation: reduces swelling and pain after eye surgery.
• Anterior uveitis: controls intra‑ocular inflammation and prevents tissue damage.
• Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergens.
• Iridocyclitis: suppresses inflammation of the iris and ciliary body.
• Other inflammatory ocular conditions: manages inflammation in various eye disorders where corticosteroid therapy is appropriate.

• Dexamethasone binds to intracellular glucocorticoid receptors in ocular tissues, forming a receptor complex that translocates to the nucleus. This complex modulates gene transcription, decreasing production of pro‑inflammatory cytokines, prostaglandins, and leukotrienes while increasing anti‑inflammatory proteins. The net effect is reduced vascular permeability, inhibition of leukocyte migration, and suppression of immune activation within the eye.

Maxidex may cause a range of ocular and systemic reactions. Patients should be aware of both common and less frequent events.

Common Side Effects

• Stinging or burning sensation on instillation.
• Transient blurred vision.
• Mild ocular irritation or redness.
• Increased intra‑ocular pressure (IOP) with prolonged use.
• Temporary tearing.

Serious or Rare Side Effects

• Secondary ocular infection (bacterial, fungal, or viral).
• Cataract formation with long‑term therapy.
• Persistent elevation of IOP leading to glaucoma.
• Delayed wound healing after ocular surgery.
• Corneal ulceration or melting.
• Systemic absorption causing adrenal suppression (rare).

Before prescribing Maxidex, clinicians should consider several safety measures.

• Assess intra‑ocular pressure: monitor IOP regularly during treatment.
• Avoid use in active viral ocular infections: may exacerbate viral replication.
• Use with caution in diabetic patients: steroids can raise blood glucose levels.
• Do not wear contact lenses: may retain drug and increase irritation.
• Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Maxidex can interact with other ophthalmic agents, requiring careful management.

Major Interactions (Avoid)

• Systemic corticosteroids: additive systemic glucocorticoid effects may increase risk of adrenal suppression.
• Anticholinergic eye drops: may reduce ocular clearance and enhance steroid exposure.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory eye drops (NSAIDs): combined use can increase risk of corneal melting.
• Antiviral ophthalmic agents (e.g., ganciclovir): may diminish antiviral efficacy.
• Beta‑blocker eye drops: potential additive effect on intra‑ocular pressure.
• Herbal supplements affecting wound healing (e.g., ginseng): monitor for delayed recovery.